OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-β type I receptor

Por Chuannan Fan, Qian Wang, Gerard van der Zon, Jiang Ren, Cedrick Agaser, Roderick C. Slieker, Prasanna Vasudevan Iyengar, Hailiang Mei, Peter ten Dijke
Publicado em 2022-04-01